This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2025 Dec 11;393(23):2382.

doi: 10.1056/NEJMc2515109.

Oral Semaglutide in Adults with Overweight or Obesity

Hongquan Liu¹, Fengze Sun¹, Jitao Wu¹

Affiliations

PMID: 41370812
DOI: 10.1056/NEJMc2515109

Comment

Oral Semaglutide in Adults with Overweight or Obesity

Hongquan Liu et al. N Engl J Med. 2025.

. 2025 Dec 11;393(23):2382.

doi: 10.1056/NEJMc2515109.

Authors

Hongquan Liu¹, Fengze Sun¹, Jitao Wu¹

Affiliation

¹ Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.

PMID: 41370812
DOI: 10.1056/NEJMc2515109

No abstract available

PubMed Disclaimer

Comment on

Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity.
Wharton S, Lingvay I, Bogdanski P, Duque do Vale R, Jacob S, Karlsson T, Shaji C, Rubino D, Garvey WT; OASIS 4 Study Group. Wharton S, et al. N Engl J Med. 2025 Sep 18;393(11):1077-1087. doi: 10.1056/NEJMoa2500969. N Engl J Med. 2025. PMID: 40934115 Clinical Trial.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.